Washington Free Beacon The American Academy of Child and Adolescent Psychiatry has vetoed at least three panels with European clinicians about their efforts to limit gender care.
A top pediatric psychiatry organization has nixed at least three panels with leading European psychologists about Europe’s move away from chemical interventions for children with gender dysphoria, raising questions about the politicization of American medicine and underscoring a clinical divide between the United States and much of the world.
The American Academy of Child and Adolescent Psychiatry (AACAP), which sets practice guidelines for the field, rejected one panel in 2022 and two more this May on the advice of its “Gender Identity Committee,” whose co-chair, Aron Janssen, has described restrictions on puberty blockers and cross-sex hormones as an “effort to oppress.”
Each panel would have taken place at the group’s annual conferences—research-cum-networking bonanzas that draw thousands of professionals—and would have featured clinicians from countries that have restricted access to those drugs, allowing their use only in clinical trials or after long periods of psychological vetting. The speakers planned to discuss the data that led Finland, Sweden, and England to abandon the more laissez-faire treatment model now dominant in the United States, according to emails and panel proposals reviewed by the Washington Free Beacon.
Read Full Article Here…(freebeacon.com)
Home | Caravan to Midnight (zutalk.com)
Live Stream + Chat (zutalk.com)
